Cancer is probably the one word no one wants to hear. If you’ve recently been diagnosed with a gastrointestinal stromal tumor (GIST), a relatively rare cancer found in the digestive tract, you ...

Finding out that you have gastrointestinal stromal tumor (GIST) can feel overwhelming, especially since it is such an uncommon type of cancer.You may have questions about how your life will change ...

A gastrointestinal stromal tumor (GIST) is a tumor that develops in the GI tract. Learn about the symptoms, causes, treatment options, and more here.

The overall GIST survival rate for 5 years is 85%. However, many factors, including the tumor's size, location, and a person's age and overall health can affect their survival. Learn more here.

On GIST Awareness Day, Dr. Sicklick was in Moores Cancer Center’s rare-tumor clinic dedicating his day to his patients and their families. Moores’ clinic is one of only a handful of clinics ...

Background Gastrointestinal stromal tumor (GIST) is known for its wide variability in biological behaviors and it is difficult to predict its malignant potential. The aim of this study is to ...

Researchers at Fox Chase Cancer Center uncovered a genetic pattern that may help predict how gastrointestinal stromal tumor (GIST) patients respond to the targeted therapy imatinib mesylate (Gleevec).

Steady progress has been made in our understanding of the pathogenesis of gastrointestinal stromal tumors (GIST). The tyrosine kinas inhibitor, imatinib, exhibits impressive anti-tumor effects ...